Irritable bowel syndrome (IBS) was the focus of two recent studies this month, which analyzed patients with symptoms of diarrhea-predominant IBS and IBS after infectious enteritis.
Use of gastric acid suppressants was linked with increased risk of recurrent Clostridium difficile infection and of first-time ischemic stroke in recent research.
Patients with cirrhosis were the focus of several recent studies, which reviewed the evidence behind nutritional assessment, calculated the cost-effectiveness of hepatocellular carcinoma screening, and estimated the prevalence of nonalcoholic
Studies published in May found a potential benefit of statin therapy for three different conditions.
The past month's gastroenterology research may not have been simple as ABC, but it did focus on the major types of hepatitis, including a hepatitis A outbreak, a comparison of hepatitis B drugs, and new data on hepatitis C complications and incidence
Recommendations from the U.S. Preventive Services Task Force, the Kidney Disease: Improving Global Outcomes (KDIGO) work group, and the Choosing Wisely campaign all focused on hepatitis C virus (HCV) infection.
The American Association for the Study of Liver Diseases, the American Gastroenterological Association, the American College of Gastroenterology, and the U.S. Preventive Services Task Force all released new guidelines this month.
In the past month, researchers assessed potential treatments of irritable bowel syndrome (IBS), reviewed likely causes of the condition, and quantified the daily challenges facing patients with IBS.
Two recent studies focused on fecal microbiota transplantation for recurrent Clostridium difficile infection, while a third examined the utility of anaerobic preparations in patients with mild to moderately active ulcerative colitis.
One recent study assessed occurrence of hepatocellular carcinoma in patients with hepatitis C-associated cirrhosis, while another looked at the effect of hepatobiliary cancer surveillance on outcomes in patients with primary sclerosing cholangitis.